Andrew E. Singer is CFO & VP at Epizyme, Inc. (EPZM). They have made 9 open-market trades across 1 company since 2016, most recently 2017-08-09.
CIK 0001571498
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EPZM | 45,446 | $67K |
Shares reported on the most recent Form 4, priced at the 2017-08-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EPZM | SELL · 10b5-1 | 2017-06-30 | 2017-07-05 | $15.50 | $47K | -8.4% | -8.7% | +24.5% |
| EPZM | SELL · 10b5-1 | 2017-03-31 | 2017-04-03 | $17.09 | $34K | -7.6% | +4.0% | -4.9% |
| EPZM | SELL | 2017-01-09 | 2017-01-10 | $12.04 | $24K | -17.2% | +2.1% | +22.2% |
| EPZM | SELL · 10b5-1 | 2016-12-09 | 2016-12-12 | $11.03 | $11K | +1.3% | -0.4% | +44.2% |
| EPZM | SELL · 10b5-1 | 2016-11-09 | 2016-11-10 | $10.40 | $11K | -4.8% | +0.9% | +9.2% |
| EPZM | SELL | 2016-10-10 | 2016-10-12 | $9.72 | $20K | -0.6% | +32.0% | +32.6% |
| EPZM | SELL · 10b5-1 | 2016-09-09 | 2016-09-12 | $7.55 | $8K | +22.1% | +14.0% | +44.1% |
| EPZM | SELL | 2016-08-09 | 2016-08-10 | $9.05 | $18K | -8.0% | -17.5% | +15.9% |
| EPZM | SELL · 10b5-1 | 2016-07-11 | 2016-07-13 | $10.36 | $10K | +1.1% | -15.6% | -3.5% |
| EPZM | SELL | 2016-06-09 | 2016-06-10 | $12.49 | $25K | -8.5% | -11.7% | -31.8% |
| EPZM | SELL | 2016-05-09 | 2016-05-12 | $9.79 | $20K | +19.2% | +28.2% | -3.1% |
| EPZM | SELL | 2016-04-11 | 2016-04-13 | $12.42 | $13K | -6.3% | -30.4% | -18.5% |
| EPZM | SELL | 2016-03-09 | 2016-03-11 | $9.33 | $9K | -4.0% | +11.0% | +12.0% |
| EPZM | SELL | 2016-02-10 | 2016-02-10 | $9.54 | $116K | -1.7% | +14.0% | +7.1% |
| EPZM | SELL | 2016-02-10 | 2016-02-10 | $9.54 | $116K | -1.7% | +14.0% | +7.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.